Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–6 of 6 results
Advanced filters: Author: Huizhen Ye Clear advanced filters
  • Designing photocatalysts to enhance the efficiency of non-oxidative coupling of methane is a challenging task. Here, the authors report that the anatase TiO2 with exposed {101} facets and Pd co-catalyst enables efficient and selective methane coupling to ethane via a heterogeneous-homogeneous hybrid reaction pathway.

    • Huizhen Zhang
    • Pengfei Sun
    • Ye Wang
    ResearchOpen Access
    Nature Communications
    Volume: 15, P: 1-10
  • Alkoxycarbonylation reactions are widely used in the chemical industry, but their sustainability is often hindered by inefficient CO utilization. Here, the authors tackle the challenge by developing a sustainable and efficient carbonylation process for producing methyl propionate, achieving high CO utilization and regioselectivity.

    • Bin Zhang
    • Haiyang Yuan
    • Graham J. Hutchings
    ResearchOpen Access
    Nature Communications
    Volume: 15, P: 1-13
  • The selective reduction of α, β-unsaturated carbonyls remains a challenge. Here the authors report a zinc-based catalyst for this reaction, converting α, β-unsaturated carbonyl compounds into unsaturated alcohols followed by hydrodeoxygenation to form alkenes.

    • Tianjiao Wang
    • Yu Xin
    • Buxing Han
    ResearchOpen Access
    Nature Communications
    Volume: 15, P: 1-10
  • Protective immune mechanism induced by live-attenuated double-deleted L. monocytogenes ∆actA/∆inlB vaccine strain delivering tumor antigens keeps hepatobiliary malignancies under control. Live-attenuated, double-deleted L. monocytogenes ∆actA/∆inlB strain expressing model tumor antigen was used in both, prophylactic and therapeutic vaccination settings. Vaccination was safe and led to: (i) induction of protective tumor-specific Th1 immune responses in premalignant and malignant stages and strong increase of tumor-specific IFN-ɣ+ CD4 and CD8 T cells; (ii) decrease of T regulatory cells; (iii) downregulation of several tumor-promoting ICI molecules (PD-1, CD160, LAG3, 4-1BBL) on CD4/CD8 T lymphocytes; (iv) decrease of tumor-specific IgG in serum, and (v) decrease of B lymphocytes, DC and MΦ locally in livers. iCCA, intrahepatic cholangiocarcinoma.

    • Inga Hochnadel
    • Lisa Hoenicke
    • Tetyana Yevsa
    ResearchOpen Access
    Oncogene
    Volume: 41, P: 2039-2053